The Complainant is the holding company of the Novartis group, which is a global pharmaceutical and healthcare group trading as “Novartis”. It is headquartered in Switzerland and was created in 1996 through a merger of Ciba-Geigy and Sandoz.<\/p>\n
In 2022 the Novartis group employed approximately 102,000 full-time employees and acquired net sales of over USD 50 Billion.<\/p>\n
The Complainant owns various trademarks consisting of the work NOVARTIS, including the above mentioned US trademark. It is also the registrant for many domain names containing the word NOVARTIS.<\/p>\n
The disputed domain name was registered recently on 28 June 2023. At the commencement of the proceedings it resolved to a parking webpage containing pay-per-click advertising.<\/p>\n
On 2 August 2023 an internet user received an email from <hr@novartisjob-us.com> purporting to offer employment with “Novartis Pharmaceuticals Corporation” and detailing a registration process whereby information is requested from the internet user. The email attached a document which displayed the Complainant’s logo. The name “Novartis Pharmaceuticals Corporation” is used by the Novartis group’s United States of America corporate entity.<\/p>\n
In the registration details for the disputed domain name the Respondent has provided its name as “Sandoz Pharmaceutical” with an address in “Princeton, New Jersey” in “Romania”<\/p>", "other_legal_proceedings": "
The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "
NO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED. <\/p>", "rights": "
The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "
The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "
The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "
The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Andrew Sykes" ], "date_of_panel_decision": "2023-09-25 00:00:00", "informal_english_translation": "
United States of America Trademark Registration No. 4986124 NOVARTIS with a priority date of 12 September 2013 for various pharmaceutical and health related goods and services.<\/p>", "decision_domains": { "novartisjob-us.com ": "TRANSFERRED" }, "panelist": null, "panellists_text": null }